Brain Cancer Vaccine Shows Promise

A potential vaccine for brain cancer led to a nearly 50 percent improvement in survival time among patients suffering from glioblastoma multiforme — the same cancer that killed Sen. Edward Kennedy.

The vaccine, made from brain cancer patients’ own tumor cells, is known as HSPPC-96. It was tested in a phase 2 clinical trial involving approximately 40 patients with recurrent glioblastoma, an aggressive brain cancer that usually kills patients within 15 months of diagnosis.

For more information, click here to read the full article.